Discovery and validation of human genomic safe harbor sites for gene and cell therapies.
Aznauryan E, Yermanos A, Kinzina E, Devaux A, Kapetanovic E, Milanova D, Church GM, Reddy ST
Cell Rep Methods. 2022 Jan 14;2(1):100154. doi: 10.1016/j.crmeth.2021.100154. eCollection 2022 Jan 24.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
ID | Plasmid | Purpose |
---|---|---|
179861 | Rogi2-CMV-mRuby-bGH | Targets Rogi2 genomic region with HDR and expresses mRuby |
179864 | Rogi1-CMV-LAMB3-T2A-GFP-bGH | Targets Rogi1 genomic region with HDR and expresses LAMB3-T2A-GFP |
179865 | Rogi2-CMV-LAMB3-T2A-GFP-bGH | Targets Rogi2 genomic region with HDR and expresses LAMB3-T2A-GFP |